Lexicon Pharmaceuticals Inc (LXRX:NASDAQ) Annual Reports & Investor Relations Material

Overview

Lexicon Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of potential drug candidates for various human diseases. The company is committed to developing innovative solutions for diseases that have no cure, with a focus on scientifically valid approaches to drug discovery. Lexicon is dedicated to improving the quality of life for patients and is working hard to bring new treatments to market. The company has a promising pipeline of potential drug candidates, and its research is gaining attention in the healthcare industry.

Frequently Asked Questions

What is Lexicon Pharmaceuticals Inc's ticker?

Lexicon Pharmaceuticals Inc's ticker is LXRX

What exchange is Lexicon Pharmaceuticals Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Lexicon Pharmaceuticals Inc's headquarters?

They are based in The Woodlands, Texas

How many employees does Lexicon Pharmaceuticals Inc have?

There are 51-200 employees working at Lexicon Pharmaceuticals Inc

What is Lexicon Pharmaceuticals Inc's website?

It is lexpharma.com

What type of sector is Lexicon Pharmaceuticals Inc?

Lexicon Pharmaceuticals Inc is in the Healthcare sector

What type of industry is Lexicon Pharmaceuticals Inc?

Lexicon Pharmaceuticals Inc is in the Biotechnology industry

Who are Lexicon Pharmaceuticals Inc's peers and competitors?

The following five companies are Lexicon Pharmaceuticals Inc's industry peers:

- Syndax Pharmaceuticals

- Cyclerion Therapeutics, Inc.

- SELLAS Life Sciences Group, Inc.

- Ardelyx Inc

- Vertex Pharmaceuticals